supp.fit

Chondroitin and Glucosamine: study protocols

24 study groups took Chondroitin together with Glucosamine. These are the doses the studies gave. They are not a recommendation.

Chondroitin: what the research found →

Dose per serving from research: Chondroitin

24 study groups in 22 studies say how much Chondroitin participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 1 g to 2.5 g, 54% of 24 study groups.

Daily doseStudy groups
50 mg to 100 mg
2
100 mg to 250 mg
3
250 mg to 500 mg
0
500 mg to 1 g
6
1 g to 2.5 g
13

Dose per serving from research: Glucosamine

23 study groups in 21 studies say how much Glucosamine participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 1 g to 2.5 g, 74% of 23 study groups.

Daily doseStudy groups
500 mg or less
1
500 mg to 1 g
5
1 g to 2.5 g
17

Commonly used together

7 of 24 study groups took Chondroitin and Glucosamine with something else, but nothing that 3 or more different studies gave.

24 study groups

Study
Clinical risk factors associated with radiographic osteoarthritis progression among people with knee pain: a longitudinal study
2021 · glucosamine sulfate and chondroitin sulfate (double active) · Adults aged 45–75 with symptomatic knee osteoarthritis
800 mg1.5 g2 years—
Combined glucosamine and chondroitin sulfate, once or three times daily, provides clinically relevant analgesia in knee osteoarthritis
2015 · GIII · Adults with radiographic knee osteoarthritis, Kellgren/Lawrence grade 2–3; age and sex not specified
1.2 g1.5 g16 weeks306
Combined glucosamine and chondroitin sulfate, once or three times daily, provides clinically relevant analgesia in knee osteoarthritis
2015 · GI · Adults with radiographic knee osteoarthritis, Kellgren/Lawrence grade 2–3; age and sex not specified
1.2 g1.5 g16 weeks302
Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study
2016 · GC group · Men and women aged 40–75 with moderate-to-severe knee osteoarthritis
1.2 g1.5 g180 days66
Effectiveness of Cucumis sativus extract versus glucosamine-chondroitin in the management of moderate osteoarthritis: a randomized controlled trial
2018 · GC Group · Males and females aged 40–75 years with mild to moderate knee osteoarthritis
600 mg750 mg180 days61
Effects of N-acetyl glucosamine and chondroitin sulfate supplementation on knee pain and self-reported knee function in middle-aged and older Japanese adults: a randomized, double-blind, placebo-controlled trial
2016 · Glu/Cho group · Japanese adults aged 52–87 with knee pain and/or stiffness
180 mg100 mg24 weeks50
Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis: A Double Blind Randomized Controlled Trial
2017 · GCM · Patients with Kellgren-Lawrence grade I-II knee osteoarthritis; age and sex not specified
1.2 g1.5 g90 days50
Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis: A Double Blind Randomized Controlled Trial
2017 · GC · Patients with Kellgren-Lawrence grade I-II knee osteoarthritis; age and sex not specified
1.2 g1.5 g90 days49
Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial
2009 · Glucosamine HCl plus chondroitin sulfate group (G+C) · Adults with moderate to severe osteoarthritis of the knee; age and sex distribution not specified for this arm.
600 mg750 mg90 days26
The effect of oral low molecular weight liquid hyaluronic acid combination with glucosamine and chondroitin on knee osteoarthritis patients with mild knee pain: An 8-week randomized double-blind placebo-controlled trial
2021 · A+HA group · Men and women aged 40 years or older with knee osteoarthritis and mild knee pain
250 mg750 mg8 weeks24
A randomized double-blind clinical trial of the effect of chondroitin sulfate and glucosamine hydrochloride on temporomandibular joint disorders: a pilot study
2001 · active medication group · People diagnosed with capsulitis, disk displacement, disk dislocation, or painful osteoarthritis of the temporomandibular joint
1.2 g1.5 g12 weeks14
Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis
2000 · intervention group · Adults with knee osteoarthritis; age and sex not reported
1.6 g2 g26 weeks—
Potential effects of chondroitin sulfate on joint swelling: a GAIT report
2008 · glucosamine plus chondroitin sulfate · Adults with symptomatic, radiographic knee osteoarthritis
1.2 g1.5 g24 weeks—
Effect of a dietary supplement containing glucosamine hydrochloride, chondroitin sulfate and quercetin glycosides on symptomatic knee osteoarthritis: a randomized, double-blind, placebo-controlled study
2012 · GCQ supplement · Japanese subjects with symptomatic knee osteoarthritis
60 mg1.2 g16 weeks—
Curcumagalactomannoside/Glucosamine Combination Improved Joint Health Among Osteoarthritic Subjects as Compared to Chondroitin Sulfate/Glucosamine: Double-Blinded, Randomized Controlled Study
2020 · Group II (CHN-GLN) · Adults with confirmed class I–III osteoarthritis; ages not reported; 38 males and 42 females across both groups
830 mg1 g12 weeks—
Treatment of knee osteoarthritis with a new formulation of a fixed-dose combination of glucosamine sulfate and bovine chondroitin: a multicenter, randomized, single-blind, non-inferiority clinical trial
2021 · GS/CS group · Patients with knee osteoarthritis, Kellgren-Lawrence grades 2 or 3, with a mean WOMAC pain subscale score of at least 40 mm
1.2 g1.5 g24 weeks—
Glucosamine-containing supplement improves locomotor functions in subjects with knee pain: a randomized, double-blind, placebo-controlled study
2015 · GCQID group · Japanese women and men aged 40–74 years with knee pain
60 mg1.2 g16 weeks50
Effects of cartilage-supporting nutritional supplementation on knee osteoarthritis symptoms and quality of life in a 12-week randomized double-blind placebo-controlled pilot study
2025 · Verum · Adults with mild-to-moderate knee osteoarthritis and slight-to-moderate knee pain; mean age 62.7 years; women and men
200 mg—12 weeks36
Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study
1999 · combination therapy · male U.S. Navy diving and special warfare personnel with chronic pain and radiographic degenerative joint disease of the knee or low back
1.2 g1.5 g16 weeks—
Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens
2015 · glucosamine-chondroitin combination · Adults aged 45–75 with chronic knee pain and medial tibio-femoral compartment narrowing consistent with symptomatic knee osteoarthritis
800 mg1.5 g2 years151
Differences in Serum Biomarkers Between Combined Glucosamine and Chondroitin Versus Celecoxib in a Randomized, Double-blind Trial in Osteoarthritis Patients
2020 · Combined glucosamine hydrochloride plus chondroitin sulfate (GH+CS) · Patients with knee osteoarthritis; age and sex not specified
1.2 g1.5 g26 weeks96
Randomized trial of glucosamine and chondroitin supplementation on inflammation and oxidative stress biomarkers and plasma proteomics profiles in healthy humans
2015 · Glucosamine and chondroitin (G&C) intervention · Healthy, overweight, non-smoking men and women aged 20–55 years
1.2 g1.5 g4 weeks18
Effects of glucosamine-chondroitin combination on synovial fluid IL-1β, IL-6, TNF-α and PGE2 levels in internal derangements of temporomandibular joint
2015 · study group · Women aged 18–40 with internal derangement of the temporomandibular joint, pain lasting longer than 4 weeks, and limitation in mouth opening
1.2 g1.5 g8 weeks—
Influence of a low-dose supplementation of curcumagalactomannoside complex (CurQfen) in knee osteoarthritis: A randomized, open-labeled, active-controlled clinical trial
2021 · GLN-CHN combination group · Adults with knee osteoarthritis
830 mg1 g6 weeks—